Demant's top-line growth in line with outlook, Jefferies assesses
![Photo: Richard Drew/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14490344.ece/ALTERNATES/schema-16_9/20190524-170848-4-5760x3234ma.jpg)
Demant’s top-line growth looks to be in line with previous predictions, writes investment bank Jefferies after the Danish hearing aid manufacturer’s CEO, Søren Nielsen, and president for diagnostics and communications, Arne Boye Nielsen, took to the stage at industry conference EUHA.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Demant on the sidelines until OTC proves its worth
For subscribers